Analytical Lens: Exploring EyePoint Pharmaceuticals Inc (EYPT)’s Financial Story Through Ratios

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.97 million shares were traded. EYPT stock price reached its highest trading level at $10.745 during the session, while it also had its lowest trading level at $10.08.

Ratios:

Our analysis of EYPT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.01 and its Current Ratio is at 5.08. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on January 22, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.

On November 02, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $20.

On April 21, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $33.Robert W. Baird initiated its Outperform rating on April 21, 2023, with a $33 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 12 ’24 when GUYER DAVID R sold 11,625 shares for $10.06 per share. The transaction valued at 116,995 led to the insider holds 1,850 shares of the business.

GUYER DAVID R sold 11,625 shares of EYPT for $119,705 on Jun 03 ’24. The Director now owns 3,700 shares after completing the transaction at $10.30 per share. On May 14 ’24, another insider, GUYER DAVID R, who serves as the Director of the company, sold 11,625 shares for $12.65 each. As a result, the insider received 147,045 and left with 5,550 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EYPT now has a Market Capitalization of 548969600 and an Enterprise Value of 255343312. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.97 while its Price-to-Book (P/B) ratio in mrq is 2.10. Its current Enterprise Value per Revenue stands at 5.105 whereas that against EBITDA is -3.005.

Stock Price History:

The Beta on a monthly basis for EYPT is 1.62, which has changed by -0.11946535 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, EYPT has reached a high of $30.99, while it has fallen to a 52-week low of $5.67. The 50-Day Moving Average of the stock is 0.78%, while the 200-Day Moving Average is calculated to be -34.30%.

Shares Statistics:

EYPT traded an average of 1.21M shares per day over the past three months and 923000 shares per day over the past ten days. A total of 49.04M shares are outstanding, with a floating share count of 49.04M. Insiders hold about 5.84% of the company’s shares, while institutions hold 105.36% stake in the company. Shares short for EYPT as of 1719532800 were 9629305 with a Short Ratio of 7.96, compared to 1717113600 on 7743543. Therefore, it implies a Short% of Shares Outstanding of 9629305 and a Short% of Float of 21.78.

Most Popular